Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose versus full-dose yellow fever vaccine trial in Kenyan and Ugandan adults and children
PACTR202110902331170Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Nov 2019
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 4 trial of 17D yellow fever vaccine in yellow fever (2 arms), sponsored by University of Oxford. Primary endpoint: Seroconversion by PRNT-50. Started Nov 2019; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on PACTR202110902331170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202110902331170.